Navigation Links
Novel Anti-Inflammatories May Offer a New Approach for the Treatment of Stroke
Date:6/25/2012

Los Angeles, California (PRWEB) June 25, 2012

New evidence supporting the potential value of a new type of anti-inflammatory treatment for stroke published last week in the Journal of Cerebral Blood Flow & Metabolism[1]. The new animal study documented more than 40% reduction in stroke size(volume) and neural deficit after treatment with a new TNF-alpha decoy receptor fusion protein, a class of drugs originally developed to treat forms of arthritis. This new study is the latest in a series of animal experiments that goes back more than a decade and follows publication last year of the first human results of the use of a TNF-alpha decoy receptor fusion protein following stroke[2]. The human study, performed at the Institute of Neurological Recovery (INR) in Los Angeles, documented rapid and sustained improvement following treatment at the INR. News reports (see below) have documented the striking potential of the revolutionary new INR treatment approach.

Scientific Background

Stroke produces tissue damage in the brain that causes a detrimental inflammatory response and elevation of the levels of a protein, TNF, that amplifies inflammation. TNF-alpha decoy receptor fusion proteins, such as etanercept, and other biologic TNF inhibitors reduce the damage caused by excess levels of TNF. These new stroke studies suggest that TNF-alpha decoy receptor fusion proteins may have the potential to improve brain function, if administered in ways that allow brain penetration. The INR in Los Angeles and Boca Raton, Florida has pioneered patented [3] anti-TNF methods for treatment of neuroinflammatory disorders, including stroke, Alzheimer's disease, and sciatica. Rapid clinical improvement in brain function in AD following the use of a TNF-alpha decoy receptor fusion protein has been documented on 60 Minutes in Australia in their feature entitled "A New Shot at Life" and in the scientific literature[4].

For further information, please see the website of the Institute of Neurological Recovery: http://www.strokebreakthrough.com

References
1. Sumbria, R.K., et al., Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab, 2012.
2. Tobinick, E., Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs, 2011. 25(2): p. 145-55.
3. Issued and pending U.S. and international patents, including, but not limited to U.S. patents 6,982,089; 7,629,311; 7,214,658; and 8,119,127, all assigned to TACT IP, LLC and Australian patent 758,523.
4. For further scientific references please see the INR website Scientific Publications webpage.

© 2012 Institute of Neurological Recovery (INR®)

Read the full story at http://www.prweb.com/releases/2012/6/prweb9633325.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
2. Rutgers team discovers novel approach to stimulate immune cells
3. Novel drug candidates offer new route to controlling inflammation
4. Researchers present new findings for novel pancreatic cancer vaccine
5. Novel biomarkers reveal evidence of radiation exposure
6. VCU Massey Cancer Center sees potential in novel leukemia treatment
7. Study supports urate protection against Parkinsons disease, hints at novel mechanism
8. Novel Natural Sciences Repository Opens Web Portal
9. Experts Offer Advice After Yankee Pitchers Trampoline Injury
10. Mayo Clinic offers newly approved treatment for acid reflux disease
11. Here Are Fruits, Veggies That Offer Best Bang for Your Buck
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2019)... ... December 14, 2019 , ... For two years, the only ... modular buildings. Driving into the parking lot would make you think of the temporary ... is simple. Hurricane Irma devastated the old building and the hospital carried on, first ...
(Date:12/9/2019)... , ... December 09, 2019 ... ... in innovative solutions that help food and manufacturing companies engage with their ... program. This turnkey solution helps manufacturers build a cohesive culture that is ...
(Date:12/8/2019)... ... December 08, 2019 , ... Intelligent.com, a trusted resource ... Logistics Degree Programs for 2020. The comprehensive research guide is based on an ... evaluated based on curriculum quality, graduation rate, reputation, and post-graduate employment. , ...
(Date:12/6/2019)... ... December 06, 2019 , ... In ... students in Salt Lake Community College’s (SLCC) Emergency Medical Technician (EMT) ... Chelise Schaefer—were awarded the AT&T Public Safety Hero Scholarship to support their first ...
(Date:12/6/2019)... , ... December 06, 2019 , ... TIME For ... 2019, spotlighting a mix of educational, innovative, and fun destinations that are tailored to ... of the 50 coolest places. , To assemble the list, TIME for Kids gathered ...
Breaking Medicine News(10 mins):
(Date:12/14/2019)... Calif. (PRWEB) , ... December ... ... group Attorneys for the Rights of the Child (ARC) ( http://www.arclaw.org ) ... circumcision (VMMC) program in Africa, though only on boys mostly 15 years ...
(Date:12/9/2019)... Conn. and WALNUT CREEK, Calif. (PRWEB) , ... ... ... the nation’s leading technology-based solutions to optimize healthcare provider savings across purchased services ... Sharp is the leading healthcare provider in San Diego County with four acute ...
(Date:12/9/2019)... (PRWEB) , ... December 09, 2019 , ... ... cysts most people contend with are not ‘sebaceous,’” notes Dr. Robert Levine, a ... usually epidermoid – also called ‘epidermal’ – cysts, which have their own distinct ...
Breaking Medicine Technology: